Navigation Links
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Date:1/28/2011

ition of rights to intellectual property assets; market acceptance of our future products; government regulation of the pharmaceutical industry;  Endo's dependence on a small number of products; Endo's dependence on outside manufacturers for the manufacture of a majority of its products;  Endo's dependence on third parties to supply raw materials and to provide services for certain core aspects of its business; new regulatory action or lawsuits relating to Endo's or Qualitest's use of narcotics in many of its core products; Endo's and Qualitest's exposure to product liability claims, market withdrawals and product recalls and the possibility that Endo may not be able to adequately insure itself; the successful efforts of manufacturers of branded pharmaceuticals to use litigation and legislative and regulatory efforts to limit the use of generics and certain other products; Endo's ability to successfully implement its acquisition and in-licensing strategy; regulatory or other limits on the availability of controlled substances that constitute the active ingredients of some of its products and products in development; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by third parties or the government, and the performance of indemnitors with respect to claims for which we have been indemnified; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of its total revenues; a determination by a regulatory agency that Endo is engaging or has engaged in inappropriate sales or marketing activities, including promoting the "off-label" use of its products, the risk that demand for and acceptance of our products or services may be reduced; the risk of changes in governmental regulations; the impact of economic conditions; the impact of competition and pricing and other risks and uncertainties, including those detailed from time to
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
3. JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement
4. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
7. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
8. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
9. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
10. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
11. Amylin Pharmaceuticals to Webcast Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... JUNCTION, N.J. , Nov. 21, 2014 /PRNewswire/ ... company commercializing its European Union approved CytoSorb® cytokine ... worldwide, was awarded the Beacon of Light Award ... Awards Celebration.  Dr. Phillip ... "It is an honor to be recognized by ...
(Date:11/22/2014)... LONG BEACH, Calif. , Nov. 21, 2014   ... implants. Dental implants are often called the gold standard in ... teeth. They are a stable, long-lasting way to restore and ... use dental implants to replace a missing tooth or as ... to completely transform the look and feel of a smile. ...
(Date:11/22/2014)... , Nov. 21, 2014 MEDITE Group acquired ... nine months and the 3 rd quarter sales ended ... income was $448,000 for the nine months ended September 2014 ... "Even though our 3 rd quarter is usually a ... extends from July into September for many countries worldwide, we ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3
... 2010 The board of directors of Pfizer Inc. (NYSE: ... dividend on the company,s common stock, payable March 1, 2011, ... February 4, 2011.  Pfizer increased the dividend by approximately 11 ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) "This dividend increase is a ...
... Out of hundreds of Medicare Advantage ... SNP) is one of only five plans across the country that ... from the Centers for Medicare and Medicaid Services (CMS). ... and drug plans perform on a scale of one to five, ...
Cached Medicine Technology:Pfizer Declares A 20-Cent First-Quarter 2011 Dividend 2IEHP Earns Highest Rating for Medicare Part D Quality and Performance 2
(Date:11/22/2014)... 2014 (HealthDay News) -- A clinical trial of hydroxyurea ... halted a year early because the results show it ... disease and reduce the risk of stroke. The ... medical centers in the United States and Canada, was ... and Blood Institute (NHLBI). Researchers compared monthly blood ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Those air-blown ... germs than conventional paper towels, a new study suggests. ... on the hands of volunteers in order to simulate ... dryers, high-powered "jet-air" dryers or paper towels to dry ... and found higher amounts of germs around both types ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
(Date:11/21/2014)... CRN International, the radio marketing and ... professional to its award-winning team. , Leslie Heinemann, most ... and sales experience to CRN. She will be based ... Director of Strategy and Development, reporting to CRN Managing ... will handle a wide range of territories and market ...
(Date:11/21/2014)... FL (PRWEB) November 21, 2014 Body Well ... announced that it accepts Spafinder massage gift cards ... in room hotel massage in all service areas including throughout ... don't have to go to the spa at all to ... and Founder of Body Well. "We may not be able ...
Breaking Medicine News(10 mins):Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Restroom Hand Dryers Spread More Germs Than Paper Towels, Study Finds 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:Radio Industry Veteran Joins CRN International’s Sales Organization in Detroit 2Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2
... America,s Health (TFAH) released a new report today ... change plan that includes a public health response. This includes ... natural disasters, pollution, and infectious diseases as temperatures and sea ... Climate Change and the Public,s Health report examines U.S. ...
... years of experience in cancer research and patient care, ... released today the most comprehensive, risk-based screening guidelines publicly ... The new recommendations represent the first wave ... the effectiveness of efforts to prevent and detect cancer ...
... MD, a principal investigator at Los Angeles Biomedical Research ... one of India,s highest honors, the "Hind Rattan Award," ... presents annually for "outstanding services, achievements and contributions" by ... Welfare Society will present the honor to Dr. Mehrotra ...
... SCOTTSDALE, Ariz. A new Mayo Clinic study suggests that ... uses wireless technology in diagnosing intestinal disease, is safe ... as cell phones, have been shown to interfere with ... has led medical experts to speculate that capsule endoscopy ...
... world,s fastest supercomputer, Roadrunner, at Los Alamos National ... accelerated petascale computer modeling and simulations of a ... Roadrunner system is now beginning its transition to ... reliability of the U.S. nuclear deterrent. ...
... Park live to be nearly six years old, their ability to ... a study led by Dan MacNulty and recently published online by ... December print issue. The finding challenges a long-held ... It now appears that like human athletes, they are only at ...
Cached Medicine News:Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 2Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 3Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 4Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 2Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 3Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 4Health News:LA BioMed researcher to be honored 2Health News:Mayo Clinic study shows people with heart devices can 'digest' advanced diagnostic technology safely 2Health News:Mayo Clinic study shows people with heart devices can 'digest' advanced diagnostic technology safely 3Health News:Science at the petascale: Roadrunner results unveiled 2Health News:Science at the petascale: Roadrunner results unveiled 3Health News:Wolves lose their predatory edge in mid-life, new U of Minnesota study shows 2
Cholesterol/HDL Standard 50 mg/dl....
For the quantitative determination of High Density Lipoprotein in serum. Available in liquid type. Polyethylene glycol (6000) precipitating reagent. Linearity: 200 mg/dl....
... Intended for the ... in plasma. Two vials, ... Enzymatic, alphaketoglutarate. Uses NADPH ... other plasma compounds. Reaction: ...
... The ProteomeLab XL-A/XL-I functions over a ... strength and pH, delivering more thorough ... operating methodology measures the relative change ... providing an efficient way to measure ...
Medicine Products: